Good Seed: The Dave’s Killer Bread Story–2012


 

Good Seed: The Dave’s Killer Bread Story–2012 – Watch the inspiring story of Dave Dahl, founder of Dave’s Killer Bread and former ex-con / prodigal son of pioneering organic baker, Jim Dahl. Based in Milwaukie, Oregon, Dave’s Killer Bread was awarded the 2011 “Oregon Ethics in Business Award” and “Local Hero Award” by Edible Portland magazine. “Killer Dave” Dahl (though he never killed anyone) along with his brother, Glenn Dahl, and nephew, Shobi Dahl, transformed a small family bakery into a Northwest business phenomenon, and their bread lines are now carried from California to Alaska in stores like Fred Meyer, Safeway, Costco, WinCo, Whole Foods and QFC to name but a few. Their company slogan, “Just say no to bread on drugs” and vision, “to make the world a better place, one loaf of bread at a time,” has been quoted in media outlets including MSNBC, Inc. Magazine, the New York Times, and LifeTime. The mission of Dave’s Killer Bread is “to bake the highest quality wholegrain and organic bread without compromise,” as well as “contribute positively to the community and create a respectful and enjoyable place for our employees to work.” … History The history of Dave’s Killer Bread begins in 1955, when Dave’s father, Jim Dahl, purchased a small neighborhood bakery on 123rd and Division in Portland called Midway Bakery. A “pioneer” in sprouted wheat bread-baking, James soon found a following for his delicious breads made with whole grains and no animal fats (a rarity at that time). His most successful and well-known

 

European Markets for Diabetes Monitoring, Treatment and Drug Delivery

Filed under: drug treatment programs in nyc

The European market for diabetes diagnosis, treatment and drug delivery is expected to exceed €7.7 billion by 2019. This market includes traditional blood glucose meters, continuous glucose monitoring systems, blood glucose test strips, lancets and …
Read more on PR Newswire (press release)

 

Whoa! What Just Happened to My Stock?

Filed under: drug treatment programs in nyc

Drug developer Keryx Biopharmaceuticals bounced higher yesterday as investors shrugged off analyst questions about whether its treatment for patients with end-stage renal disease who suffer from high serum phosphorus levels would have the five-year …
Read more on Motley Fool

 

Free Research Report on Southwestern Energy Co., Mylan, Inc., Sandridge

Filed under: drug treatment programs in nyc

NEW YORK, NY–(Marketwire – Feb 6, 2013) – Today, Traders Insight announced new research reports highlighting Southwestern Energy Co. ( NYSE : SWN), Mylan, Inc. ( NASDAQ : MYL), Sandridge Energy, Inc. ( NYSE : SD) and … The Company's product is for …
Read more on Marketwire (press release)